A cross-platform validated biomarker signature for mucoepidermoid carcinoma identified by integrated WGCNA and machine learning.
Mucoepidermoid carcinoma (MEC), the most prevalent malignant salivary gland cancer, remains incompletely characterized at the molecular level. An integrated analytical pipeline was employed, combining differential expression analysis, weighted gene co-expression network analysis (WGCNA), resampling-based stability sele...